Search

You searched for "ophthalmologists"

3148 results found

Congenital dacryocystocele in UK

1 October 2018 | | EYE - Oculoplastic, EYE - Orbit
The authors report the first national study of dacryocystocoeles in UK. They report an incidence of one in 18,597 live births in the UK for congenital dacryocystocele. A prospective observational study of 49 cases of congenital dacryocystocele presenting between September...
Ophthalmic Epidemiology cover picture

Can diuretics increase the risk of acute angle closure glaucoma?

4 December 2024 | | EYE - Glaucoma
Diuretics, used widely in the treatment of hypertension, oedema, heart failure and liver failure, have been implicated in case reports in scientific literature to be linked to bilateral acute angle closure glaucoma (AACG). The aim of this study was to...

‘Pete’s Bogus Journey’ An autobiographical descent through a career in medicine now available.

20 February 2023
There is no doubt that life is a bogus journey and it does not end well for any of us.

South-South collaboration for the treatment of avoidable blindness in Botswana

1 October 2017 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
This article describes the value of South-South collaboration in the reduction of avoidable blindness. Specifically it describes a South-South collaboration between India and Botswana that evolved out of the VISION 2020 LINK between Cambridge University Hospitals, two institutions in India...

Broadening of treatment options for potentially blinding retinal conditions

2 August 2022 | | EYE - General
Rod McNeil provides an update on a promising bispecific antibody recently approved for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) and considers emerging developments in biosimilars to established anti-vascular endothelial growth factor (anti-VEGF) therapies, including...

Report on preoperative visual acuities of patients from two AMM surgical trips to Magdalena, Northern Bolivia

3 October 2024 | | EYE - Glaucoma, EYE - General
The Andean Medical Mission (AMM), founded in 2012, recently celebrated 12 years of dedicated service in the Bolivian Amazon, aiming to eliminate avoidable blindness. Over this period, AMM has successfully performed over 1700 surgeries, including for children with congenital or...

Coming to terms with AI

1 August 2019 | | EYE - Imaging, EYE - Vitreo-Retinal, EYE - Glaucoma, EYE - General
A machine might be called intelligent if its response to questions could convince a person that it was human, a test proposed by Alan Turing in 1950 [1]. The author considers potential applications of artificial intelligence (AI) using machine learning...

Implementing technology to improve global eye health

3 October 2024 | | EYE - Vitreo-Retinal
Technological innovation is providing new solutions to transform global eye health [1–5]. In particular, research towards the development of artificial intelligence (AI) tools in ophthalmology has gained pace in recent years. However, there has been little research relating to its...

A life outside ophthalmology

3 April 2023 | | EYE - General
Lloyd Paul Aiello. It was an absolute privilege to speak to Lloyd Paul Aiello, Professor of Ophthalmology, Harvard Medical School, and Vice President of Ophthalmology and Director, Beetham Eye Institute, Joslin Diabetes Center, USA. Prof Aiello is a third-generation ophthalmologist,...

Rb-NET: a network to save life and preserve vision in children in Africa

1 April 2018 | | EYE - Pathology, EYE - Oncology
Responding to need is a key element underpinning the VISION 2020 LINKS Programme [1]. It is embedded in the process through which LINKS are established, with institutions in low- and middle-income countries (LMICs) first defining their priority areas of training...

How to access research funding- experiences from the inside track @ 100% Ophthalmology

24 February 2024
@15:15 – 16:15 The panel will aim to encourage members of the audience to consider applying to Fight for Sight and other vision charities.

Allied eye healthcare networking @ 100% Ophthalmology

24 February 2024
@16:15 – 17:00 With technology advancing so much, SD-OCT is a more sensitive diagnostic tool than wide field FAF imaging for detecting early-stage HCQ-induced maculopathy. Wide field FAF may not be a necessary addition to SD-OCT in detecting HCQ toxicity. Richard Bell, Co-Chair - British Association of Retinal Screening